Ranibizumab Recommended for Diabetic Macular Edema

An advisory committee to the US Food and Drug Administration (FDA) voted to recommend ranibizumab (Lucentis, Genentech, Inc) for the treatment of diabetic macular edema.
Medscape Medical News